ClinicalTrials.gg
TerminatedNCT03928626Updated Feb 28, 2024

Brief ROC Training Effects on Alcohol Drinking

An interventional study of Regulation of craving and Control (NO REGULATION) in Binge Drinking, Heavy Drinking and Young Adult, sponsored by Yale University. Terminated at 1 site in United States. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-28.

Sponsored by Yale University · Not applicable, Interventional, and Treatment

Why this study was terminated
Study stopped due to COVID shutting down all research at Yale University.
Phase
Not applicable
Study type
Interventional
Enrollment
57
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The goal of the proposed study is to examine whether a single session of training in regulation of craving (ROC-T) affects alcohol drinking. The study will consist of (1) a basic screening (phone and/or online) and an in-person visit, to determine eligibility and conduct pre-intervention baseline assessments; (2) a training (ROC-T) visit, (3) a post-intervention assessment visit, and (4) 1-2 phone/online follow-up assessments.

The study will take up to 10 hours of the participants' time.

Read the detailed description

The investigators propose to test the efficacy of such training by randomizing 120 individuals who report alcohol drinking to the following conditions: (1) a brief training in cognitive regulation and (2) a control or no-training condition. Training will be delivered in a computerized session (approximately 60 minutes). If randomized into the cognitive regulation training, subjects will be trained to use a cognitive strategy while viewing images of alcoholic drinks. The strategy would be to follow instructions to think about the adverse outcomes associated with continued alcohol drinking. If randomized into the control condition, participants will only view non-alcohol-related images with no use of strategy. After all the training sessions are completed, participants will complete several follow-ups. The investigators will evaluate the effects of training on alcohol drinking pre- and post-training.

02

Conditions studied

  • Binge Drinking
  • Heavy Drinking
  • Young Adult
  • Heavy Drinker
  • Alcohol Drinking
  • Alcohol Drinking in College
  • Drinking Behavior
  • Drunkenness
  • Drinking Excessive
  • Drinking Problem
  • Drink Too Much
  • College Drinking

Keywords

  • Binge Drinking
  • Heavy Drinking
  • Young Adult
  • Heavy Drinker
  • Regulation of craving
  • Cognitive behavioral therapy
  • Neurocognitive training
  • Emotion regulation
  • Alcohol
03

In context

Binge Drinking

71 studies on the registry are indexed under Binge Drinking; 20 are open to participants now.

This study's enrollment of 57 is below the median of 120 across 64 interventional studies indexed under Binge Drinking.

Browse Binge Drinking studies →

Lead sponsor

Yale University is the lead sponsor of 1,770 studies on the registry; 294 are open to participants now.

Of its 221 completed or terminated interventional studies of FDA-regulated products, 129 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adults ages 18-25
  2. Capability of performing the experimental tasks (e.g., can read, able to use computers)
  3. Native or fluent speaker of English
  4. Provides
  5. Normal or corrected-to-normal vision
  6. Willing to commit to the full length of the protocol
  7. Heavy drinking or binge-drinking

Exclusion criteria

Exclusion Criteria.

  1. Present DSM disorders, apart from alcohol use disorders
  2. Reports of neurological or systemic disorders that can cause cognitive impairment
  3. Minor cognitive impairment evidenced by an inability to correctly understand study information
  4. Reports entirely no interest in reducing the amount of drinking (Alcohol Contemplation Ladder score of 9 or 10).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
57 participants (actual)

Study arms

  • Active comparator
    CRAVING REGULATION

    In the CRAVING REGULATION condition, participants will first read a brief essay about the adverse consequences of drinking alcohol. Then, participants may complete a comprehension check consisting of questions to ensure that they understood and encoded the content of the essays. Participants will be trained to use the information to inform the strategy they will use in the regulation of craving training (ROC-T). A single trial in the regulation of craving training will have two possible instructions: (a) STRATEGY: implement the strategy ("bring to mind the negative facts from the essay") and (b) LOOK: to merely observe the image and allow natural responses to come. Participants will follow the instructions; followed by an alcohol-related picture, a brief delay, and will then rate their craving. Participants will then be instructed to use this strategy in daily life situations when they might drink.

    Behavioral: Regulation of craving

  • Placebo comparator
    CONTROL (NO REGULATION)

    In the CONTROL condition, participants will first read a brief essay about a non-alcohol-related topic (e.g., color perception). Then, participants will complete a comprehension check consisting of questions to ensure that they understood and encoded the content of the essays. Participants will view images of objects that are unrelated to alcohol. Furthermore, participants in the control condition will not practice any strategy in the regulation of craving task (ROC-T). That is, in the CONTROL condition, participants would merely observe the image and allow natural responses to come (i.e., LOOK instruction) and rate how colorful is each item (this controls for task time and experiment setting).

    Behavioral: Control (NO REGULATION)

Interventions

  • BehavioralRegulation of craving

    Participants in the ROC-T condition will be trained to use a strategy that instructs them to think of the negative outcomes associated with alcohol drinking while looking at alcohol-related images.

    Also known as: Neurocognitive training

  • BehavioralControl (NO REGULATION)

    In the CONTROL condition, participants would simply observe non-alcohol-related images and allow natural responses to come

    Also known as: Sham (No regulation)

06

What researchers measure

Primary outcomes

  1. Timeline followback (TLFB)

    The Alcohol TLFB is a drinking assessment method that obtains estimates of daily drinking.

    Time frame: Baseline (first visit) to post-intervention (an average of one week after first visit)

Secondary outcomes

  1. Frequency of regulating drinking + craving.

    Participants will be asked to report their craving regulation (if any) since the intervention. In order to assess the level of craving regulation the participants will answer several questions in our craving regulation questionnaire. This assessment will include questions about the number of attempts at craving regulation, the number of times the participant intended to regulate craving, one's confidence in one's ability to regulate craving, the level of motivation to regulate drinking before each drinking episode, and the participant's intention to regulate drinking in the future. Finally, participants will be asked how many times they were thinking of negative consequences in general and while experiencing alcohol craving.

    Time frame: Will be measured at post-intervention (one week after first visit)

  2. Timeline followback (TLFB)

    The Alcohol TLFB is a drinking assessment method that obtains estimates of daily drinking.

    Time frame: First visit, post-intervention (one week after first visit), follow-up (two weeks after first visit)

07

Study locations

1 site
  • Clinical & Affective Neuroscience Lab
    New Haven, Connecticut 06510, United States
08

References and documents

Individual participant data

Plan to share: No — IPD will not be shared with other researchers.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2019 to primary completion in Mar 2020, 11 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 11, 2019
First posted
Apr 26, 2019
StartActual
Apr 10, 2019
Primary completionActual
Mar 15, 2020
CompletionActual
Mar 15, 2020
Last update
Feb 28, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03928626
Lead sponsor
Yale University
Responsible party
Sponsor
First posted
Apr 26, 2019
Start date
Apr 10, 2019
Primary completion
Mar 15, 2020
Completion
Mar 15, 2020
Last update
Feb 28, 2024

Study contacts

Uri Berger, PhD
study director · Yale University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion